Mohamed Zaki
CIK 2000697 · View on SEC EDGAR ↗
First SEC filing: Jan. 2, 2024 · Latest: Jan. 2, 2024
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 30, 2026 | ADCT | A | 213,900 | — | — | 896,317 Direct | +31.34% | Acquired | (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
ADCT
Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2025 | $690,121 | — | $370,300 | — | $431,325 | — | $23,820 | $1,515,566 |
| 2024 | $670,020 | — | — | — | $318,260 | — | $21,233 | $1,009,513 |
| 2023 | $647,292 | $1,475,000 | $288,900 | $1,701,000 | $276,250 | — | $15,409 | $4,403,851 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.